Search research articles
Contact Us
Filters
Showing results (1-10 of 246) with videos related to
Page
of 25
Sort By:
Haematologica
|
November 5, 2017
Knockdown of <i>TP53</i> in <i>ASXL1</i> negative background rescues apoptotic phenotype of human hematopoietic stem and progenitor cells but without overt malignant transformation
Susan Hilgendorf, Edo Vellenga
Current Opinion in Hematology
|
March 24, 2010
Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells
Jan J Schuringa, Edo Vellenga
Critical Reviews in Oncology/Hematology
|
October 9, 2019
Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy
Katharina Mattes, Edo Vellenga, Hein Schepers
Plos One
|
November 1, 2014
ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML
Marta E Capala, Edo Vellenga, Jan Jacob Schuringa
Experimental Hematology
|
June 28, 2003
Stem cell factor enhances erythropoietin-mediated transactivation of signal transducer and activator of transcription 5 (STAT5) via the PKA/CREB pathway
Arjen-Kars Boer, A Lyndsay Drayer, Edo Vellenga
Blood
|
January 17, 2003
Decreased phosphorylation of protein kinase B and extracellular signal-regulated kinase in neutrophils from patients with myelodysplasia
Gwenny M Fuhler, A Lyndsay Drayer, Edo Vellenga
Stem Cells International
|
September 20, 2016
Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models
Pallavi Sontakke, Jenny Jaques, Edo Vellenga, et al.
Molecular and Cellular Biology
|
September 10, 2008
Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels
Albertus T J Wierenga, Edo Vellenga, Jan Jacob Schuringa
Annals of Hematology
|
April 14, 2010
Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases
Lina Han, Jan Jacob Schuringa, André Mulder, et al.
Critical Reviews in Oncology/Hematology
|
October 23, 2015
Constitutive NF-κB activation in AML: Causes and treatment strategies
Matthieu Cornelis Johannes Bosman, Jan Jacob Schuringa, Edo Vellenga
Page
of 25
Search research articles
Search
Showing results (1-10 of 246) with videos related to
Sort By:
Page
of 25
Haematologica
|
November 5, 2017
Knockdown of <i>TP53</i> in <i>ASXL1</i> negative background rescues apoptotic phenotype of human hematopoietic stem and progenitor cells but without overt malignant transformation
Susan Hilgendorf, Edo Vellenga
Current Opinion in Hematology
|
March 24, 2010
Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells
Jan J Schuringa, Edo Vellenga
Critical Reviews in Oncology/Hematology
|
October 9, 2019
Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy
Katharina Mattes, Edo Vellenga, Hein Schepers
Plos One
|
November 1, 2014
ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML
Marta E Capala, Edo Vellenga, Jan Jacob Schuringa
Experimental Hematology
|
June 28, 2003
Stem cell factor enhances erythropoietin-mediated transactivation of signal transducer and activator of transcription 5 (STAT5) via the PKA/CREB pathway
Arjen-Kars Boer, A Lyndsay Drayer, Edo Vellenga
Blood
|
January 17, 2003
Decreased phosphorylation of protein kinase B and extracellular signal-regulated kinase in neutrophils from patients with myelodysplasia
Gwenny M Fuhler, A Lyndsay Drayer, Edo Vellenga
Stem Cells International
|
September 20, 2016
Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models
Pallavi Sontakke, Jenny Jaques, Edo Vellenga, et al.
Molecular and Cellular Biology
|
September 10, 2008
Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels
Albertus T J Wierenga, Edo Vellenga, Jan Jacob Schuringa
Annals of Hematology
|
April 14, 2010
Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases
Lina Han, Jan Jacob Schuringa, André Mulder, et al.
Critical Reviews in Oncology/Hematology
|
October 23, 2015
Constitutive NF-κB activation in AML: Causes and treatment strategies
Matthieu Cornelis Johannes Bosman, Jan Jacob Schuringa, Edo Vellenga
Page
of 25